TrialJournal of pharmacokinetics and pharmacodynamics2020

A time-to-event analysis of the exposure-response relationship for bezlotoxumab concentrations and CDI recurrence.

Ka Lai Yee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.